Cyanotech Corporation (CYAN)
Market Cap | 2.91M |
Revenue (ttm) | 24.22M |
Net Income (ttm) | -3.20M |
Shares Out | 7.23M |
EPS (ttm) | -0.45 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 17,300 |
Average Volume | 5,564 |
Open | 0.4100 |
Previous Close | 0.4000 |
Day's Range | 0.4100 - 0.4600 |
52-Week Range | 0.2300 - 0.8900 |
Beta | -0.29 |
RSI | 61.22 |
Earnings Date | Jun 24, 2025 |
About Cyanotech
Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction and research and develo... [Read more]
Financial Performance
In 2024, Cyanotech's revenue was $24.22 million, an increase of 4.96% compared to the previous year's $23.07 million. Losses were -$3.20 million, -39.19% less than in 2023.
Financial StatementsNews
Cyanotech GAAP EPS of -$0.45, revenue of $24.22M

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q4 & FYE 2025.

The Sun's Out. So Is the Secret to UV and Sun Support from Within.
How One Hawaiian Microalgae Farm Is Advancing Sun Care with BioAstin® Hawaiian Astaxanthin® A new conversation in sun care is emerging — one that goes beyond the surface and into the science of suppor...
Cyanotech GAAP EPS of -$0.03, revenue of $6.17M

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2025
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q3FY25 and First Nine Months of Fiscal 2025.
Cyanotech (CYAN) Stock Plummets Over 16% on OTC Market
Cyanotech (CYAN) Stock Plummets Over 16% on OTC Market

Spirulina Beverages Market and Consumer Behaviour Analysis, 2025-2030 - Prolgae Spirulina Supplies, Cyanotech Corporation, FUL Foods, Sol-Ti, and Raw Juicery Lead the Projected $61 Million Market
Online Retail for Spirulina Beverages Positioned to Witness the Highest CAGR During the Forecast Period Online Retail for Spirulina Beverages Positioned to Witness the Highest CAGR During the Forecast...
Q2 2025 Cyanotech Corp Earnings Call Transcript
Q2 2025 Cyanotech Corp Earnings Call Transcript
Cyanotech GAAP EPS of -$0.16, revenue of $5.85M

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2025
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q2FY25 and First Six Months of Fiscal 2025.

CYAN Stock Surges 6.58% on U.S. OTC Market Amid Sector Decline
CYAN (CYAN, Financial), a company listed on the U.S. OTC market, experienced a significant stock price increase of 6.58%. The stock is currently trading at $0.81 per share with a trading volume of 6,8...

Red Robin And 3 Other Stocks Under $5 Executives Are Buying
The Dow Jones index closed lower by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and trad...

Eos Energy Enterprises And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and trade...

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2025
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q1FY25.

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q4FY24 and Fiscal Year 2024.

Cyanotech Corporation (CYAN) Q3 2024 Earnings Call Transcript
Cyanotech Corporation (NASDAQ:CYAN) Q3 2024 Results Conference Call February 9, 2024 8:00 PM ET Company Participants Matt Custer - President and CEO Felicia Ladin - CFO Matt Custer Aloha from Kona, H...

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q3FY24.

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024.

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024.

Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment.

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023.

Top 5 Defensive Stocks That Are Set To Fly
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced fi...

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023

ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS
The New Board Members Will Bring Industry Experience to Contribute to Company Growth WOODINVILLE, Wash. , Nov. 2, 2022 /PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology c...